Stoke Therapeutics Inc. (STOK)
Market Closed
1 Sep, 20:00
$
30. 89
-0.31
-0.9936%
$
2.04B Market Cap
- P/E Ratio
- Div Yield
726,701 Volume
-2.44 Eps
$ 31.2
Previous Close 
Want to track STOK and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
Stoke Therapeutics Inc. (STOK) Statistics
Valuation metrics
Market Cap 2.04B
Enterprise value 1.93B
Trailing P/E (ttm) -9.41
Forward P/E -11.21
PEG ratio -0.07
Price/Sales (ttm) 73.96
Price/Book (mrq) 6.04
Enterprise Value/Revenue 70.07
Enterprise Value/EBITDA -9.41
Overview
Shares outstanding 58.92M
Float 43.83M
Shares short 12.82M
% Held by insiders 0.04%
% Held by institutions 1.19%
Average volume (10 days) 754.1K
Average volume (90 days) 677.87K
Price summary
52-Week low 18.8
52-Week high 40.22
Beta 1.22
50-Day moving average 30.5
200-Day moving average 32.9
Financials
Fiscal year
Fiscal year ends 31 Dec 2025
Most recent quarter (mrq) 31 Dec 2025
Profitability
Profit margin -7.54%
Operating margin -8.1%
Operational effectiveness
Return on assets -0.53%
Return on equity -0.59%
Income Statement
Revenue (ttm) 184.42M
Revenue per share (ttm) 0.42
Quarterly revenue growth (yoy) -0.94%
Gross profit (ttm) 184.42M
EBITDA -18.82M
Net income to common (ttm) -6.88M
Diluted EPS (ttm) -3.15
Quarterly earnings growth (yoy) -0.94%
Balance Sheet
Total cash (mrq) 284.67M
Total cash per share (mrq) 4.44
Total debt (mrq) 4.15M
Total Debt/Equity (mrq) 0.01
Current ratio (mrq) 7.69%
Book value per share (mrq) 5.23
Cash Flow
Cash flow statement 45.59M
Levered free cash flow (LFCF) 33.02M
